Zeltiq Aesthetics Inc (ZLTQ) reported quarterly earnings results on Tuesday, May-10-2016. The company reported $-0.25 earnings per share for the quarter, missing the analyst consensus estimate by $-0.01. Analysts had a consensus of $-0.24. The company posted revenue of $64.50 million in the period, compared to analysts expectations of $61.87 million. The company’s revenue was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.06 EPS.
Many Wall Street Analysts have commented on Zeltiq Aesthetics Inc. Zeltiq Aesthetics Inc was Initiated by Brean Capital to “Buy” on Apr 13, 2016. Shares were Reiterated by Maxim Group on Mar 1, 2016 to “Buy” and Lowered the Price Target to $ 40 from a previous price target of $50 .
Zeltiq Aesthetics Inc closed down -0.4 points or -1.37% at $28.84 with 4,91,715 shares getting traded on Friday. Post opening the session at $29.04, the shares hit an intraday low of $28.19 and an intraday high of $29.23 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on Apr 14, 2016, Mary Fisher (director) sold 1,863 shares at $30.00 per share price. According to the SEC, on Apr 14, 2016, Mark J Foley (President and CEO) sold 13,640 shares at $29.39 per share price. On Apr 14, 2016, Sergio Garcia (Senior VP, GC & Secretary) sold 5,000 shares at $30.00 per share price, according to the Form-4 filing with the securities and exchange commission.
ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.